%201.svg){kind=icon}
Driving Global Health Innovation with AI-Powered Data Solutions
We make biomedical data AI-ready, unlocking actionable insights with scalable solutions.
Powering Precision Medicine with Multimodal AI & Data Innovation
Our AI-powered Platform- Polly integrates clinical, omics, and imaging data, accelerating R&D and driving impactful outcomes.
Establishing Best Practices in Data Security and Quality
Ensuring trusted data with robust security frameworks, stringent compliance standards, and validated quality checks for biomedical research and development organizations.
Trusted by Industry Leaders
Biopharma innovators rely on our AI-powered platform- Polly to streamline data workflows and optimize research outcomes.
%20(1).svg)
%20(1).svg)
.svg)
.svg)
%201.svg){kind=icon}
.webp)
.webp)
.webp)
.webp)
First place winners: NCI-CRDC (Cancer Research Data Commons) AI Data Readiness Challenge!
Recognized as 'Most Innovative Company in Biotech, 2024' by Fast Company!
Trusted by the World's Leading Biopharma R&D Teams
.webp)
.svg)
.webp)
.svg)
.webp)
.webp)
.svg)
.svg)
.webp)
.webp)
Polly: The Only AI-Ready Data Platform
By combining pillars of people, processes, and technology, Polly streamlines complex workflows, increases productivity, and delivers reusable, findable, access controlled AI-ready Data Products, powering end-to-end decision support.
Streamline multimodal data integration, accelerate drug discovery and development, and derive actionable insights with our scalable, AI-powered platform
Integrated Data Management
Seamlessly unify EHRs, omics, imaging, and clinical trial data in a single platform.
LLM-powered metadata extraction and enrichment for high-quality insights.
Scalable Infrastructure
Supports 26+ data types and 30+ bioinformatics pipelines.
SOC2, HIPAA, and GDPR-compliant for secure data handling.
AI-Driven Insights
AI-assisted cohort builders and dashboards for faster decision-making.
Predictive modeling and visualizations to identify high-risk patients and recommend treatment plans.
Customer Stories
AI Chatbot Optimizes Data Retrieval for Speed & Human-Level Accuracy
See how a leading pharma company harnessed Elucidata’s LLM-powered chatbot with optimized RAG to streamline data retrieval and query execution. With 2X better performance and 5X faster insights, the chatbot provides easy access to multi-modal data without coding required.
%201%20(1).svg){kind=icon}
Modernizing Gene Therapy R&D with Automated Pipelines
Discover how a US-based biopharma company optimized its AAV-genome sequencing pipeline with Elucidata. By automating virion analysis and cassette quality assessment, they achieved 0.01% plasmid purity accuracy while cutting pipeline development costs by 4X.
Accelerating Translational Research with Curated Datasets
Learn how a South San Francisco-based translational research company advanced target discovery and lowered preclinical toxicity risks with Elucidata’s data curation expertise. By building a high-quality dataset and using harmonized single-cell and bulk RNA-seq data, they boosted predictive efficiency in Treg-cell biology.
Refining Single-Cell Data Processing to Accelerate Cancer Diagnostics
Discover how a US-based cancer diagnostics company sought to improve its RNA-seq workflow for Acute Myeloid Leukemia (AML) research with Elucidata. By streamlining data ingestion, processing, and analysis, they eliminated inefficiencies, ensured seamless scalability, and saved $1.34M in compute costs.
%201%20(3).svg){kind=icon}
Quantifiable Results for Smarter Research
4X
Cheaper Data Product Generation
Cost-efficient data products built with optimized pipelines.
2X
Faster Model Development
Accelerates deployment and time to market for therapies.
$2M+
Annual Cost Savings
Achieved through reduced operational costs and scalable solutions.
Find the Right Use Case for Your Data
%20(1).svg)
Target Identification
Rapidly identify targets with harmonized multi-omics data. Validate existing targets with relevant public studies.
%20(1).svg)
Biomarker Prediction
Predict diagnostic or prognostic biomarkers by analyzing Bulk RNA-seq Samples from Polly.
%20(1).svg)
Meta-analysis
Integrate gene expression studies to identify target genes or enriched pathways in a selected indication.
%20(1).svg)
Signature Exploration
Use Polly’s signature database to identify indications related to a gene signature, or find drugs that reverse a disease signature.
%20(1).svg)
Cell Type Annotation
Identify, extract, and annotate cell types or subtypes from single-cell datasets using a custom marker list.
%20(1).svg)
Patient Stratification
Train ML classifiers on curated RNA-seq data to accurately segment patient cohorts for a specific indication.
Target Identification
Rapidly identify targets with harmonized multi-omics data. Validate existing targets with relevant public studies.
Biomarker Prediction
Predict diagnostic or prognostic biomarkers by analyzing Bulk RNA-seq Samples from Polly.
Meta-analysis
Integrate gene expression studies to identify target genes or enriched pathways in a selected indication.
Signature Exploration
Use Polly’s signature database to identify indications related to a gene signature, or find drugs that reverse a disease signature.
Cell Type Annotation
Identify, extract, and annotate cell types or subtypes from single-cell datasets using a custom marker list.
Patient Stratification
Train ML classifiers on curated RNA-seq data to accurately segment patient cohorts for a specific indication.
%202.svg){kind=icon}
%203.svg){kind=icon}
AI-Driven Biomedical Data Solutions
.svg)
.svg)
.svg)
info@elucidata.io
%201%20(1).svg)
%20(1).svg)
%201%20(1).svg)
.svg)